Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Elife|June 7, 2017
Inter-Fork Strand Annealing causes genomic deletions during the termination of DNA replicationCarl A Morrow, Michael O Nguyen, Andrew Fower, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 21, 2020
Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapiesRonan N McGinty, Adam Handel, Teresa Moloney, et al.JCI Insight|November 27, 2025
Cellular immune endophenotypes separating early and late-onset myasthenia gravisJakob Theorell, Nicolas Ruffin, Andrew Fower, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersSofia Toniolo, Sijia Zhao, John Broulidakis, et al.Proceedings of the National Academy of Sciences of the United States of America|February 6, 2024
Ultrahigh frequencies of peripherally matured LGI1- and CASPR2-reactive B cells characterize the cerebrospinal fluid in autoimmune encephalitisJakob Theorell, Ruby Harrison, Robyn Williams, et al.Proceedings of the National Academy of Sciences of the United States of America|June 6, 2022
Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disordersValentina Damato, Jakob Theorell, Adam Al-Diwani, et al.Frontiers in Immunology|October 30, 2024
Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brainCordelia Dunai, Claire Hetherington, Sarah A Boardman, et al.Biorxiv : the Preprint Server for Biology|January 27, 2025
Permissive central tolerance plus defective peripheral checkpoints licence pathogenic memory B cells in CASPR2-antibody encephalitisBo Sun, Dominique Fernandes, Anne-Kathrin Kienzler, et al.Science Advances|April 16, 2025
Permissive central tolerance plus defective peripheral checkpoints license pathogenic memory B cells in CASPR2-antibody encephalitisBo Sun, Dominique Fernandes, John Soltys, et al.Nature Communications|December 22, 2023
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responsesBenedict D Michael, Cordelia Dunai, Edward J Needham, et al.Pageof 1